Back to search

Article

Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate Cancer

2024-12-23

Abstract excerpt

Prostate cancer represents the second most frequently diagnosed malignant tumour in males. Serum PSA is used as a screening tool for prostate cancer. However, there are limitations to this approach due to the number of false positives it generates, which can result in overdiagnosis and over-treatment. The objective of this study was to identify accurate DNA methylation markers for the diagnosis of prostate cancer....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46416707-1a23-5f73-a764-bd58737b3a07
DOI
10.20944/preprints202412.2005.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Multiple Highly Methylated CpG Sites as Potential Epigenetic Markers for the Diagnosis of Prostate CancerDOI 10.20944/preprints202412.2005.v1
Select a neighboring publication to make it the new centre.